180. ATR-X syndrome Disease details / Clinical trials / Drug dev / DR info /
Clinical trial : 1 / Drugs : 2 - (DrugBank : 1) / Drug target gene : 0 - Drug target pathway : 0
Drugs, Primary sponsors and Trial info (Enrollment year, Phase, Trial ID, Countries)
5-ALA
Wada Takahito
2022 Phase 2 JPRN-jRCT2051220062 -
Aminolevulinic acid
Wada Takahito
2022 Phase 2 JPRN-jRCT2051220062 -
Wada Takahito
2022 Phase 2 JPRN-jRCT2051220062 -
Aminolevulinic acid
Wada Takahito
2022 Phase 2 JPRN-jRCT2051220062 -